# Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients

> **NCT04852796** · — · COMPLETED · sponsor: **Centre Hospitalier de Cornouaille** · enrollment: 1000 (actual)

## Conditions studied

- Covid19
- Hematologic Malignancy
- Vaccine Response Impaired

## Interventions

- **OTHER:** Patients with hemopathy

## Key facts

- **NCT ID:** NCT04852796
- **Lead sponsor:** Centre Hospitalier de Cornouaille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852796, "Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04852796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*